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ADHD? Attitudes and knowledge among
first-contact gatekeepers: systematic
narrative review
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Abstract
Background: Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood disorder with international
prevalence estimates of 5 % in childhood, yet significant evidence exists that far fewer children receive ADHD
services. In many countries, ADHD is assessed and diagnosed in specialist mental health or neuro-developmental
paediatric clinics, to which referral by General (Family) Practitioners (GPs) is required. In such ‘gatekeeper’ settings,
where GPs act as a filter to diagnosis and treatment, GPs may either not recognise potential ADHD cases, or may
be reluctant to refer. This study systematically reviews the literature regarding GPs’ views of ADHD in such settings.
Methods: A search of nine major databases was conducted, with wide search parameters; 3776 records were
initially retrieved. Studies were included if they were from settings where GPs are typically gatekeepers to ADHD
services; if they addressed GPs’ ADHD attitudes and knowledge; if methods were clearly described; and if results for
GPs were reported separately from those of other health professionals.
Results: Few studies specifically addressed GP attitudes to ADHD. Only 11 papers (10 studies), spanning 2000–2010,
met inclusion criteria, predominantly from the UK, Europe and Australia. As studies varied methodologically,
findings are reported as a thematic narrative, under the following themes: Recognition rate; ADHD controversy
(medicalisation, stigma, labelling); Causes of ADHD; GPs and ADHD diagnosis; GPs and ADHD treatment; GP ADHD
training and sources of information; and Age, sex differences in knowledge and attitudes.
Conclusions: Across times and settings, GPs practising in first-contact gatekeeper settings had mixed and often
unhelpful attitudes regarding the validity of ADHD as a construct, the role of medication and how parenting
contributed to presentation. A paucity of training was identified, alongside a reluctance of GPs to become involved
in shared care practice. If access to services is to be improved for possible ADHD cases, there needs to be a
focused and collaborative approach to training.
Keywords: Attention-deficit hyperactivity disorder, ADHD, General practice, Family practice, Gatekeepers, Attitudes,
Systematic review, Training
Abbreviations: ADHD, Attention-deficit hyperactivity disorder; CAMHS, Child and adolescent mental health services;
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Background
Attention-deficit hyperactivity disorder (ADHD) is a
common behavioural disorder of childhood, charac-
terised by over-activity, impulsivity and inattention, and
is recognised to cause significant personal, academic and
social functioning. Marked variation exists in cited
prevalence rates, which range from as high as 26 % [1, 2]
to lows of 1 %, but once methodological differences are
controlled for, international studies suggest a 5–7 % child-
hood prevalence [3–5] with an accepted worldwide pooled
prevalence of 5.29 %. Up to two-thirds of young people
who meet criteria for ADHD receive neither diagnosis nor
services, as indicated in large-scale national data sets and
community screening. In the UK, the British Child and
Adolescent Mental Health Survey found fewer than 1 in 3
young people with ADHD had seen a relevant health spe-
cialist [6]. In Ireland, parent reports in a nationally repre-
sentative sample of 8568 nine-year-olds [7] indicate that
only 1.2 % children had been diagnosed with ADHD.
Under-diagnosis and under-treatment were also reported
in a Netherlands community study of 9 year olds with
ADHD [8]. Other studies highlight complex diagnosis
rates, with evidence of both over- and under-
recognition of ADHD within the same jurisdiction, and
prevalence influenced by race, ethnicity, gender, and
age [9, 10].
In general, identifying mental health difficulties in chil-
dren and young people is a challenge in primary care
[11]. Reviews and studies in Australia, the UK, the US,
Finland, the Netherlands and elsewhere have established
that only about a third of children and adolescents with
mental health problems receive specialised care in child
and adolescent mental health services (CAMHS) [12], al-
though the proportions vary internationally, with up to
40 % children with mental health difficulties in contact
with any service in the US, compared to up to 29 % else-
where [13]. For example, in a UK community sample,
74 % children (5–11 years) who met ‘SDQ caseness’ cri-
teria had not been recognised by their GP as having a
mental health difficulty [14]. In the Netherlands, just
14 % of children whose parents or teachers thought they
had a mental health problem were recognised and diag-
nosed in general practice; many were instead identified
by school personnel [15]. GP interview techniques, the
availability and use of screening measures, level of fa-
miliarity with a child, and GP training are all thought to
influence the recognition of childhood mental health
difficulties [16].
Within a context of generally poor recognition of chil-
dren’s mental health difficulties in primary care, ADHD
may present additional challenges, as it remains a so-
cially contested diagnosis, and the subject of on-going
debate in popular media as well as in medical profes-
sions. Regarding the appropriateness of psychotropic
prescribing for children, both reasoned concerns as well
as more critical views are found [10, 17–19]. Sayal pro-
poses that in the US, physician expertise and confidence,
and an acceptance of ADHD medication use, contribute
to a higher level of ADHD recognition compared to
other jurisdictions [13]. Beyond national-level variation,
studies also indicate considerable local differences in ac-
cess and uptake of ADHD treatment [17], highlighting
the existence of other important social, medical and atti-
tudinal factors [17, 20].
For example, despite extensive research, the aetiology
of ADHD and the relationship of neurobiology to symp-
toms remain poorly understood, leaving the field open
to multiple interpretations [20, 21]. Furthermore, the
evidence for ADHD treatment continues to be actively
debated, as evidenced by the recent Cochrane meta-
analysis of methylphenidate (MPH) effectiveness in
childhood ADHD and the subsequent published debate
[22–25]. In stark contrast to previously cited reports of
high efficacy of stimulants (reflected in recommenda-
tions for use in clinical guidelines) [26, 27], the
Cochrane review authors concluded that although MPH
improves teacher-rated ADHD symptoms, general be-
haviour, and parent-rated quality of life, almost all the
evidence was of “very low quality” [22]. In many re-
sponses critiquing this finding, clinicians, researchers
and others robustly defended the evidence for MPH, tak-
ing issue with the review methodology, which they ar-
gued deviated from typical Cochrane procedure, with an
inflation of study bias and excessive downgrading of the
quality of evidence [24, 25].
In addition to debates over aetiology and treatment,
further features of the medical/social context that may
affect ADHD diagnosis, referral and treatment are med-
ical service structures and ADHD treatment guidelines.
Regarding service structures, in many countries, GPs in
primary care are service ‘gatekeepers’: for many condi-
tions, including ADHD, they do not diagnose or initiate
treatment but rather refer to relevant specialists. In such
settings, patients and their families are precluded or dis-
couraged from consulting specialists directly without GP
referral – examples are 19 countries in Europe, Canada,
Australia and New Zealand [28–31]. This contrasts with
the situation in the US and other countries, where pri-
mary care physicians predominantly provide ADHD
diagnosis and treatment and may be accessed directly
[20]. ‘Gatekeeper’ systems [28] generate multiple stages
or ‘filters’ in the help-seeking process: for example, par-
ents’ interpretations of a child’s behaviour and decisions
to consult a GP are important [13, 32, 33], but GPs hold
the key to the pathway to care [28–33]. This practice is
under-researched [34] but, as families require GP refer-
ral to access diagnosis or treatment, GP attitudes and
knowledge of a condition are crucial.
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Recommendations in guidelines, regarding who may
diagnose ADHD and initiate treatment, further under-
score GPs’ gatekeeper role. Reviews of guidelines [27, 35]
note that the American Academy of Pediatricians (AAP)
and the American Academy of Child and Adolescent
Psychiatrists (AACAP) guidelines (which are applied in
other countries outside the US) identify family physi-
cians among the professionals who may diagnose
ADHD. In contrast, national ADHD guidelines in the
UK, Canada, Scotland, New Zealand and pan-European
bodies recommend diagnosis only by specialists in sec-
ondary services – specialists to whom GPs control
referral.
In sum, GPs in gatekeeper settings are charged with
identifying children with suspected ADHD and referring
them to specialist secondary services, but they do not
engage with diagnosis or initiate treatment. Unlike many
other psychiatric diagnoses, the nature of ADHD and its
optimal treatment, despite being agreed by most psychi-
atrists and across the world in national treatment guide-
lines, is disputed by other professionals and questioned
in the media [2, 10, 18, 36]; and in many gatekeeper ju-
risdictions, the rates of children with ADHD attending
services are very low. In this context, this review aimed
to examine studies of GPs’ knowledge regarding ADHD,
focusing on those contexts where GPs are first-contact
gatekeepers to mental health services. The study sought
to answer the following questions: How do GPs who op-
erate in a gatekeeper setting self-rate their recognition of
ADHD in children and young people? Do they consider
ADHD to be a valid diagnosis? What do they identify as
causing ADHD? Which treatments do they believe are
effective? What role do they believe they should play in
the pathway to specialist service referral for ADHD?
Method
The systematic review was carried out following the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) guidelines [37]. The search
strategy was designed to be as extensive as possible to
identify all possible eligible studies, which were then re-
fined by applying inclusion and exclusion criteria. The
electronic search included the following databases:
MEDLINE, EMBASE (Elsevier), CINAHL Plus (EBSCO),
Scopus, PsycArticles (Proquest), PsycINFO (Proquest),
Social Services Abstracts, Applied Social Sciences Index
and Abstracts (ASSIA). Reference lists of included stud-
ies were screened to ensure literature saturation.
Search terms and outcome
The primary search in abstracts included three main
terms and their variations: general (family), physician
(doctor, primary care, practitioner) and attention deficit
hyperactivity disorder (ADHD, attention deficit). The
search yielded 3776 studies. Duplicates were removed
and two researchers independently reviewed 3023 titles
and abstracts according to the inclusion and exclusion
criteria listed below.
Inclusion criteria
1. Studies of GPs’ attitudes/knowledge regarding
ADHD in children and/or adolescents
2. If more than one profession is studied, GP findings
are reported separately
3. Studies in countries where GPs are first-contact
gatekeepers
4. Published in or after 1994, when DSM-IV was
published
5. Published prior to January 2015
6. English language
7. Published in peer-reviewed publications
Exclusion criteria
1. Books, chapters and book reviews; clinician review
notes, case studies, clinical practice guidelines or
recommendations; opinion pieces and
commentaries;
2. Studies of ADHD prevalence; medication adherence;
ADHD-related physical health in primary care; adult
ADHD; and studies making only passing reference
to ADHD;
3. Studies of first-contact paediatricians or child and
adolescent psychiatrists, whose training, knowledge
and recognition are likely to differ substantially
from GPs
At title screening, 710 studies were excluded and 2284
were excluded after abstract screening. Predominant rea-
sons for exclusion included studies reporting on profes-
sions other than GPs, or GP data not being reported on
separately (n = 1136); studies of ADHD measures or
medication efficacy (n = 557); or studies where ADHD
was included with other general mental health difficul-
ties, but not reported on separately (n = 250). At full-text
review, 41 studies were examined and 30 were excluded
(Fig. 1). Eleven studies did not examine GPs’ADHD atti-
tudes; most of these were studies of US-based practi-
tioners’ (paediatricians and/or family practitioners)
adherence to American Academy of Pediatrics ADHD
Guidelines, rather than their attitudes regarding ADHD.
Two studies were excluded from countries (South Africa,
Singapore) where GPs are not reported to be gatekeepers
(i.e., they may treat ADHD themselves). Finally, a recent
extensive systematic review of barriers in pathways to care
for ADHD [37] was identified, but the studies listed within
this were already identified and included by the original
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search. This review was therefore also excluded leaving 11
papers retained for synthesis (Fig. 1). Table 1 lists all in-
cluded studies with their key characteristics and findings.
Thematic narrative synthesis
Due to the heterogeneous and primarily descriptive nature
of the research identified, a thematic narrative review and
synthesis was carried out. For both quantitative and quali-
tative studies, responses were extracted and, in a line-by-
line coding process, placed in conceptually related topic
clusters or themes (Additional file 1: Table S1). The lower-
level themes were then clustered into meaningful groups
to arrive at a set of overarching themes from across the
studies.
Results
Eleven articles were identified in this review of GP attitudes
in ‘gatekeeper’ settings where national ADHD guidelines re-
quire diagnosis in secondary, specialist services (Table 1).
One UK study examined predictors of GPs’ ADHD rec-
ognition and referral practice in a London community
sample and a further 10 studies were descriptive: 6 surveys
examining GPs’ self-rated ADHD attitudes and knowledge
and 4 qualitative studies exploring GPs’ views in the UK
and Australia. The studies were published between 2000
and 2010 with a bias towards earlier in the decade: six
were of UK GPs [38–41], two from Australia [42, 43] and
one each from Canada [44], Finland [45], and Iran [46].
Topics such as ADHD existence, aetiology, management,
and GPs’ sources of information were common to several
descriptive studies. As all questionnaires were study-
specific and their content and response formats varied,
each study is briefly summarised here (further details can
be viewed in Table 1), after which the themes drawn from
across them are presented.
Community study of ADHD pathways
In a London community based study, Sayal and col-
leagues [38] examined predictors (GP and child/parent
Fig. 1 Flow diagram of the systematic review, modified from Moher et al., 2009 [37]
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Table 1 Studies included in the review of gatekeeper GP attitudes and knowledge regarding ADHD
Authors,
location
Aim and design Participants, measure, analysis Findings, conclusions Strengths and limitations
Quantitative studies
Sayal et al.
(2002) [38]
UK - London
Hyperactivity in children:
compare those who had
passed through all service
filters, with children in
community who had not.
Quantitative – identify
predictors of GP recognition
Strengths and Difficulties
Questionnaire (SDQ) sent
to 3218 parents of children
5–11 years in one London
area to identify
hyperactivity; n = 1194
completed
(40 % response; SDQ score
6+ n = 248, 21 %).
4 groups: No GP attendance;
GP attender (referred);
GP attender
(recognised, not referred);
GP attender (unrecognised).
Logistic regression; identify
predictors of recognition
Only 12 % children with pervasive
hyperactivity in community sample
were in contact with CAMHS, though
74 % had seen GP in past year.
Parent perception of problem the
only significantly predictor of GP
attendance (hyperactivity, school
burden not significant).
Non-recognition by GP was main
barrier to specialist services.
Only comorbid conduct problem or
parent referral request predicted GP
recognition, after controlling for
significant predictor variables.
As most high-risk children attend
primary care, ADHD could be
identified there, but GPs may not
recognise it if parent is unaware
or reticent.
Strong study design and
excellent response rate for
a community-based study
Ball (2001) [39]
UK - Wales
GPs’ views of ADHD
management
Quantitative survey
150 GPs (68 % response)
Postal survey. GP experience,
familiarity with ADHD,
methylphenidate.
Views of professionals’ roles,
prescribing practice, training
needs.
Descriptive frequency analysis
85 % GPs had a child with ADHD in
their practice, 89 % prescribed
methylphenidate, 94 % with
overview of child psychiatrist/
paediatrician.
No GP thought GPs should initiate
prescribing; 46 % prepared to repeat
prescribe; 54 % said primary care
could monitor physically; 64 %
psychiatry should monitor clinically.
6 % formal ADHD training, 5 %
conference/ course, 29 % journal
article, 21 % media e.g., television,
magazines.
84 % wanted further ADHD training
(68 % preferred tutorial or lecture,
27 % written, 5 % phone).
GPs overloaded, reluctant to take on
more. Study suggests CAMHS need
to provide ADHD training ADHD for
GPs and engage in discussions re
shared care
Heikkinen et al.
(2002)
Finland [45]
Primary care health centre
GPs’ self-rated child
psychiatric skills.
Quantitative survey
499 GPs (66 % response)
16-item postal questionnaire
(5-point Likert scale) on
self-rated ability regarding
children’s mood, conduct
and other disorders
Descriptive frequency analysis
Primary care health centre GPs rated
their child psychiatric skills as
inadequate in many domains.
41 % rated skill at identifying ADHD
in school-aged children as
adequate.
Medical training including CME
appears to focus less on psychiatric
than physical problems and GPs
may not consider child psychiatry to
be clearly within the primary health
care remit
Self-report of diagnostic
ability. Only 1 item
regarding ADHD.
Shaw et al.
(2002) [42]
Australia -
Queensland
Assess GP ADHD knowledge,
and actual and potential
roles in ADHD management
Quantitative survey
399 GPs (76 % response)
Randomly selected from RACGP
Directory
Survey piloted with GPs, parents,
health sociologists & statistician.
Survey explored demographics
& GP ADHD beliefs: existence;
causes; diagnosis; practice,
management; beliefs re GP role.
%s represent GP agreement with items
Aetiology: Family disruption 97 %;
parenting 77 %; poor discipline
75 %; temperament 77 %; brain
abnormality 70 %; food 12 %;
TV 7 %; video games 5 % birth
trauma 4 %; education 3 %.
Children with behaviour problems
do not have ADHD 76 %; ADHD
over-diagnosed 55 %. GPs lack
knowledge of child behaviour
Large-scale random
sample; very high response
rate.
Many T/F response
options, so chance
responding is high
Detailed and wide-ranging
questionnaire
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Table 1 Studies included in the review of gatekeeper GP attitudes and knowledge regarding ADHD (Continued)
Diagnostic criteria for ADHD,
OCD, CD, anxiety & depression
presented (n = 16); participants
asked to assign each to a
diagnosis.
Descriptive frequency analysis;
internal consistency of relevant
factors; chi-square tests
compared GP age, gender,
rural/urban
problems 74 %; ODD/CD symptom
mis-identified as ADHD 23–33 %.
1st line treatment: Behavioural 51 %,
stimulants 43 %. Stimulants: 17 %
always inappropriate, 86 % can
be abused, 40 % addictive.
GPs identified their roles as provisional
diagnosis, referral; monitoring
assistance (height, weight, appetite,
sleep); psycho-education; school
liaison. GPs wanted greater
knowledge. School input
recommended for diagnosis but
not sourced systematically. Most felt
assessing children for ADHD best
undertaken by specialists within MDT.
Barriers to greater GP involvement:
resources; addiction concern; child
behaviour problems complex; lack
of ADHD training.
GPs diagnosed only 1–5 ADHD
cases a year yet saw >550 children
4–16, so under-diagnosis likely. GP
confusion about ADHD, mood
disorders, disruptive behavioural
disorders; weak knowledge of ADHD
& comorbidities was weak; low
confidence in diagnosing and
managing.
Miller et al.
(2005) [44]
Canada – British
Columbia
GP self-report of comfort,
skill, care of children with
behavioural, emotional
problems
Quantitative survey,
inferential analyses
405 GPs (64 % response)
stratified by Health Board
region.
Postal questionnaire; 22 items
developed through
consultation.
Principal Components Analysis
(PCA) on comfort/skill items.
Repeated measures ANOVAs;
multiple linear regressions
and logistic regressions
PCA: Comfort, skill not distinct –
loaded onto single component for
each type of problem
GP self-efficacy (comfort/skill ratings)
for each problem related to CME as
well as to belief that problems are
significant and that GPs have a role
in them.
Possible that CME effects may be
due not only to knowledge
acquisition but mediated through
effects on attitudes and beliefs.
Need to bolster GP confidence, alter
attitudes, especially re ADHD &
behavioural difficulties
Large-scale study with
stratified sample and
excellent response rate,
and inferential analyses.
Salt et al. (2005)
[40]
UK - London
GP perceptions of ADHD
and its management in
primary care
Mixed methods:
Quantitative survey and
focus groups (see below)
93 GPs (52 % response) in one
London Primary Care Trust
Questionnaire: 55 ADHD items:
origins (16), symptoms (10),
attitudes (9), treatments (9),
all dichotomous; shared care
(5 items; 7 response options),
referral (6 response options).
Frequency analysis
Questionnaire
ADHD causes Most cited genetics,
chemical imbalance, quality of
parenting, family type; peers,
environment chemicals, poverty,
ethnicity, social class least cited.
Diagnostic criteria: most included
inattention, hyperactivity, impulsivity,
but > 75 % cited non-DSM
‘educational underachievement’,
‘antisocial behaviour’ and ‘sleep
problems’ as symptoms.
Treatment: 92 % methylphenidate,
followed by family & behaviour
therapy. Specialist should be
responsible, including monitoring.
Attitudes, knowledge: ADHD
controversial 90 %; media
influences attitudes 90 %; patients
can be stigmatized, disadvantaged
by ADHD diagnosis 79 %; parents
invested in child ADHD diagnosis
as it shifts blame 44 %.
ADHD exists after childhood 85 %
Small local sample, just
one primary care trust.
Most items had T/F
response options, so
chance responding is high
Detailed questionnaire and
associated qualitative
section enables deeper
interpretation
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Table 1 Studies included in the review of gatekeeper GP attitudes and knowledge regarding ADHD (Continued)
Ghanizadeh &
Zarei (2010) [46]
Iran - Shiraz
GP ADHD knowledge
Quantitative survey
665 GPs; 74 % response.
Postal questionnaire, 20 items
(dichotomous response),
previously used to assess
knowledge among teachers
& pharmacists
Frequency analyses
ADHD causes: 37 % sugar, food
additives, 53 % chaotic,
dysfunctional family, 90 %
parenting, spoiling, 83 % children
with ADHD misbehave because
they don’t want to obey rules, do
assignments;
ADHD nature: 93 % ADHD is not
lifelong; 20 % it is not serious; 75 %
can be managed with medication;
71 % psychiatrist should manage;
21 % psychologist should manage;
97 % psychological support needed.
Treatment: half against
methylphenidate use except if
severe.
ADHD information: 10 % passed
special courses on ADHD; 32 % info
from medical journals, 25 % from
media, magazines, 18 % from
colleagues
All items had T/F response
options, so chance
responding is high.
Excellent response rate
from wide-ranging sample
Qualitative studies
Klasen &
Goodman
(2000) [47]
& Klasen (2000)
[41]
UK - London
Examine attitudes of parents
and GPs regarding
hyperactivity including
barriers to treatment
Qualitative design
10 GPs from central London,
several with academic
appointments or interest in
children’s services.
Also with 29 parents of
hyperactive children, selected
purposively to achieve range of
views.
Semi-structured interviews
3 clusters of GP attitudes to ADHD
(1) ADHD labels, disempowers active
children; reframe ADHD as poor
parenting (2) Sceptical, confused by
contradictory expert opinions;
discourage medicalization, diagnosis
is stigmatising; (3) Sceptical,
diagnosis can be useful; aware of
own limitations; sympathetic
attitude to parents.
No GP had ever given a diagnosis;
believed to be task of specialists.
GPs’ decisions about referral were
moral as well as medical, based on
beliefs that diagnosis can stigmatise,
and make children passive and
dependent. They often failed to
recognize that diagnosis can
legitimate children’s and parents’
experience and reduce suffering. By
emphasising parenting factors in
ADHD, they confirmed parents’ fears
of being blamed and alienated
them.
Participants may have
been better informed
about ADHD & more
interested in it than the
average British GP
Shaw et al.
(2003) [43]
Australia -
Queensland
GP views: ADHD causes, role
in diagnosis & management,
behaviour therapy &
medication
Qualitative, as part of
mixed methods study
(see Shaw et al. 2002 [42])
28 GPs in 6 focus groups
Random selection from RACGP
Directory, (97 % response)
ADHD aetiology: Ineffective
parenting, parent stress.
Medicalisation of misbehaviour.
Identified medical management
(not parenting programmes, other
family interventions). Little interest
in management: time constraints,
knowledge, training needs. Need
diagnostic tool. Concern re media
reports of diversion. Little guidance
for GPs to determine symptoms or
clinically significant impairment;
research, guidelines do not
encompass reality of GP clinical
interview.
Random selection of GPs
and excellent response
allows high confidence in
representativeness of
findings
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factors) of ADHD care pathways. Parents and teachers
of children (5-11 years) registered with 10 London GP
practices completed the Strengths and Difficulties Ques-
tionnaire (SDQ). In cases where GP recognised hyper-
activity presentation, this always led to onward referral
to specialist services or CAMHS. Factors that increased
the likelihood of GP recognition, and subsequent refer-
ral, included parental recognition or referral request (OR
20.83, 95 % CI 3.05–142.08), and comorbid behaviour
problems (OR 1.48, 95 % CI 1.04–2.12).
Quantitative surveys of GP attitudes and knowledge
regarding ADHD
Six studies surveyed GPs’ views and knowledge regard-
ing aspects of ADHD, its nature, aetiology, diagnosis and
treatment (Table 1). Ball [39] explored GPs’ views of
ADHD diagnosis, treatment and training in South
Wales, UK, nearly all of whom prescribed methylphenid-
ate under specialist supervision. None believed a GP
should diagnose, initiate prescribing, or monitor clinic-
ally. Most wanted clearer specialist advice and medica-
tion monitoring protocols and just 6 % had received
formal ADHD training.
Shaw et al. [42] surveyed 399 GPs in Queensland,
Australia on ADHD views and knowledge. Over half
thought ADHD was over-diagnosed and three-quarters
believed that children presenting with behaviour prob-
lems do not have ADHD. Nearly all stated family and
social disruptions cause ADHD and three-quarters cited
innate temperament or organic brain abnormalities.
When asked to identify ADHD criteria from 16 DSM-IV
symptoms for 5 conditions, over half were wrong on 8
or more symptoms. GPs engaged in some assessment
activities but most would not be happy managing
ADHD, offering time constraints and lack of knowledge
as reasons. Nearly half considered stimulants the most
appropriate first-line treatment and half cited behaviour
therapy. However nearly one in five believed stimulants
were always inappropriate and almost all agreed they
have potential for abuse. Urban and female GPs were
less likely to diagnose ADHD.
In Finland, Heikkinen and colleagues [45] measured
primary care doctors’ self-evaluations of child psychiatry
skills, including one question on ADHD. Asked if they
felt well prepared to identify a child with various mental
health difficulties, fewer doctors were confident for
ADHD compared to either conduct disorder or depres-
sion, with almost half viewing themselves as poorly
skilled in identifying a child with ADHD (40.7 %).
Female GPs felt significantly more able to identify
ADHD than male GPs but there were no gender differ-
ences for conduct disorder or depression.
Salt et al. [40] surveyed views and knowledge of UK
GPs. Only a quarter believed ADHD to be well-defined.
Almost all believed ADHD to be controversial, and be-
lieved a diagnosis could be stigmatising and disadvanta-
geous. Most believed the media affect views of ADHD.
Nearly half believed parents sought diagnosis to shift
blame. Between a third and a half cited the following
causes as ‘influential’ or ‘very influential’: genetic inherit-
ance; chemical imbalance; brain damage or abnormality;
other mental health disorders; and childhood psycho-
logical trauma. Similar proportions cited parenting qual-
ity. There was high accuracy in identifying key ADHD
symptoms but most also (incorrectly) identified anti-
social behaviour and educational underachievement as
Table 1 Studies included in the review of gatekeeper GP attitudes and knowledge regarding ADHD (Continued)
Salt et al. (2005)
[40]
UK – London
GP perceptions of ADHD
and its management in
primary care
Mixed methods:
Quantitative survey
(see above) and focus
groups
13 GPs (Focus groups)
Focus groups: GP ADHD
knowledge, beliefs
(incl. aetiology, treatment);
ability to recognise, diagnose;
practice re referral, training,
management
Focus groups GPs unsure of ADHD
causes; controversial; new diagnosis;
many lack confidence. Most refer,
but not clear what they should
report. Most recommended
combination of meds and
behaviour; several said no side
effects or could not remember.
None had ADHD training in basic
medical education.
Convenience sample of
GPs from one locality only;
however can be linked to
quan study (see above)
Dennis et al.
(2008) [48]
UK - London
Professionals’ and parents’
views of ADHD and
service provision
Qualitative
5 GPs; purposive sampling
from GP practices; other
health professionals recruited
via professional networks.
Purposive sampling of voluntary
support groups for 49 parents.
Focus groups, and
semi-structured and narrative
interviews in 2 London
boroughs with 29 professionals
in total (42 % response)
Professionals more likely to see
ADHD as medical; parents
more likely to ascribe to socio-
environmental causes, often battled
with professionals to see their
viewpoint. Parent dissatisfied due
to delayed diagnosis, inadequate
information and lack of co-ordinated
care. Professionals emphasised the
need for multidisciplinary ADHD
management. Non-compliance
when parents had different
views from professionals.
Small sample from each
individual profession;
purposive sample of GPs;
limited reporting of
findings for GPs
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ADHD symptoms. Just 1 % were involved in diagnosis;
three-quarters provided repeat prescriptions, mostly
under specialist supervision. Most considered methyl-
phenidate effective but one in five believed ADHD
should not be treated with drugs.
Miller et al. [44] explored GPs’ self-perceived comfort
and skill regarding child mental health and behavioural
difficulties, including ADHD, in GPs in British
Columbia, Canada. Nearly twice as many GPs cited low
comfort and skill for diagnosing ADHD as did for diag-
nosing mood disorders. Similarly, two-thirds reported
high comfort and skill for managing childhood mood
disorders, yet only half did so for ADHD. Self-rated
comfort and skill for ADHD diagnosis or treatment were
positively associated with certification as a specialist in
Family Medicine, participation in continuing medical
education, and seeing more than five children a month
in practice, and were negatively related to GP belief that
ADHD is related to difficult stresses in the family, and
that ADHD evaluation is often subjective and difficult.
In Iran, Ghanizadeh and Zarei surveyed GPs in Shiraz
[46] about their ADHD-related views, knowledge and
practices. One in ten had passed a special ADHD course;
just under half believed they had adequate ADHD know-
ledge and relied on medical journals, media/ magazines
and colleagues; and three-quarters believed ADHD
should be managed by a psychiatrist. In terms of aeti-
ology, nearly all believed poor parenting caused ADHD;
half cited chaotic families and biological and genetic fac-
tors, and a third agreed that ADHD can often be caused
by sugar or additives. Fewer than 1 in 10 agreed that
ADHD-related difficulties are lifelong, and 1 in 5 be-
lieved ADHD was not serious and did not require
management.
Qualitative studies of GP attitudes and knowledge
regarding ADHD
In five articles, GPs’ views were explored in more depth.
Interviews with 10 London GPs were reported in Klasen
[41] and Klasen and Goodman [47]. Three stances were
found: (1) strong belief that labelling hyperactivity was
not useful; (2) sceptical and discouraging medicalisation;
and (3) believing that diagnosis was useful, providing ac-
cess to school supports and a conceptual framework for
parents (but only among GPs who had seen hyperactiv-
ity in the children of family or friends). Although several
had academic appointments or a special interest in chil-
dren’s services, GPs expressed scepticism about ADHD
and confusion about variations in expert opinion. Most
discouraged medicalisation and labelling, feeling labelling
did more harm than good, perceiving it to be stigmatising
and disempowering for a child, and self-fulfilling proph-
ecy, leading to increased conflict between parent and
child. They felt ADHD diagnosis was difficult and lacked
the certainty they expect in practice. Most GPs believed
hyperactivity was primarily due to poor parenting, inef-
fective discipline, or family stressors and that parents wish
to medicalise it to avoid addressing this. They also stated
their knowledge about hyperactivity was rudimentary; one
reflected that ‘You have to learn all about these diseases
that have a prevalence of about one in a million, and this
relatively common problem is hardly mentioned’.
Shaw et al. [43] examined GPs’ views in Queensland,
Australia. GPs believed ADHD was over-diagnosed, and
often misdiagnosed where family/parenting problems or
parent drug abuse were more relevant. They cited in-
creased stressors and technology as promoting ADHD and
were alarmed by newspaper articles about medication di-
version. They believed GPs misdiagnose ADHD because of
its complexity, and wanted a screening tool. Most believed
ADHD was overmedicated and that family and parenting
approaches should be applied more. Factors inhibiting
GPs’ involvement in ADHD management were lack of
knowledge and training; diagnostic complexity; the need
for multi-disciplinary team and specialist involvement;
and, importantly, time constraints in GP practices.
Salt et al. [40] explored 13 GPs’ views of ADHD in
London with focus groups. All were unsure as to ADHD
causes and highlighted its controversial nature, focusing on
family dysfunction. Some believed ADHD was under-
diagnosed compared to the US; others cited over-diagnosis.
One described ADHD as fashionable ‘like dyslexia and all
the rest’. More than half lacked confidence in recognising
ADHD, stressing the need for specialist involvement; most
said they would refer, but were not clear what they should
report. All were aware of methylphenidate and most
stressed a combined treatment approach. They were re-
luctant to engage in shared care and none had received
undergraduate training a ‘new diagnosis’.
Finally, Dennis et al. [48] interviewed health profes-
sionals including five GPs in two London boroughs (dis-
tricts). GPs talked about acceding to parental referral
requests, especially in ‘risk’ situations and described some
parents as expecting a ‘quick fix’. They had little interest
in being more involved in ADHD care; most felt they
could monitor physically or offer repeat prescriptions, but
specialists should provide diagnosis and clinical manage-
ment. Perceived barriers to GPs’ involvement were: a lack
of ADHD training, complex prescribing, and time and re-
source constraints of general practice.
Thematic narrative synthesis of GPs’ views and
knowledge regarding ADHD
Themes and sub-themes were formed to reflect the find-
ings from across the studies that addressed GPs’ beliefs
regarding ADHD aetiology, diagnosis, treatment, training,
and sources of information. Additional file 1: Table S1,
displays the line-by-line analysis of all themes and sub-
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themes and gives an overview of locations and times for
which these views were reported.
Themes were Recognition rate; ADHD controversy
(medicalisation, stigma, labelling); Causes of ADHD; GPs
and ADHD diagnosis; GPs and ADHD treatment; GP
ADHD training and sources of information; and Age, sex
differences in knowledge and attitudes.
Recognition rate
An ADHD screening study in the UK and GP self-
reports in Australia and Canada suggested that GPs
under-recognition of ADHD. In the UK (2002) only 1 in
10 children who screened positive for pervasive hyper-
activity using the SDQ in a community sample were in
contact with mental health services, even though 74 %
of screened children had seen the GP in the previous
year and GP hyperactivity recognition inevitably led to
referral. In Australia (2002), GPs saw over 550 children
aged 4–16 annually yet reported identifying just 1–5
ADHD cases in any given year, suggesting a recognition
rate of under 1 %. In Canada (2005), 20 % GPs said they
saw no children in whom they would consider ADHD;
this compared to only 6 % who stated they saw no chil-
dren in whom they would consider mood disorders, sug-
gesting GPs recognised ADHD less frequently than
other mental health difficulties in children, even though
prevalence data indicate ADHD is more common.
ADHD controversy (medicalisation, stigma, labelling)
In surveys and focus groups in the UK, Australia and
Iran (2000–2010), GPs typically expressed mixed feelings
and scepticism about ADHD and about medicalising
childhood behaviour, as well as concern about stigma. In
the most recent study (Iran, 2010), 1 in 5 GPs believed
ADHD was ‘not a serious problem’ that did not need to
be managed and over 8 out of 10 GPs believed children
with ADHD ‘misbehave primarily because they don’t
want to obey rules and do their assignments. In
Australia and the UK, GPs cited ADHD over-diagnosis
and discussed overmedication, medicalisation of misbe-
haviour and suspicion about medicating children. GPs in
London (2000, 2005, 2008) particularly felt that ADHD
was controversial, potentially stigmatising and disadvan-
tageous; it was considered a ‘fashionable’ diagnosis
(2005), and referrals were characterised as a risk avoid-
ance strategy (2008). Interviews in the UK (2000) identi-
fied three stances: strong anti-labelling; sceptical and
reluctant to medicalise; or ADHD diagnosis viewed as
facilitating parental understanding and school supports,
but not something GPs wished to deal with. The UK
studies also illuminated the concept of parent blame (see
Additional file 1: Table S1), as GPs described parents as
wanting to ‘shift blame’ or get a ‘quick fix’ for a child’s
behaviour. Finally, in the UK, Australia and Iran, the
media were described as influencing public attitudes to
ADHD – including GP attitudes.
Causes of ADHD GPs generally believed that ADHD
was multi-factorial (Additional file 1: Table S1). Across
times and locations, half to three-quarters of GPs (45–
77 %) cited biological, neurological or related factors,
but there was an equal or stronger emphasis on the in-
fluence of parenting, as half to nearly all (45–97 %) cited
ineffective discipline, chaotic families, marital or family
discord, or parental drug abuse. Nutrition was cited as a
cause of ADHD by 12–37 % GPs in various settings and
other environmental factors (school, media, and modern
society) were cited by up to 25 %. Other factors were cited
less frequently.
GPs and ADHD diagnosis As would be expected in set-
tings where guidelines do not recommend GP involve-
ment in formal diagnosis, almost no GPs, just 1–5 %, in
the UK, Iran & Canada, stated this was a suitable role for
them (Additional file 1: Table S1). Of concern, however,
was that almost all had low confidence in their recogni-
tion/diagnostic ability, citing their lack of training, and
complexity and uncertainty regarding ADHD. Some also
cited a need for good quality screening tools and clarity
about what they should report when referring. Two stud-
ies (Finland 2002, Canada 2005), that asked GPs to self-
rate ability to diagnose mental health difficulties including
ADHD, found it was substantially lower for ADHD than
for mood disorders in children (Additional file 1: Table
S1). Two further studies (Australia 2002, UK 2005)
assessed GPs’ ability to recognise ADHD symptoms: GPs’
identification of the three key ADHD symptoms of in-
attention, hyperactivity and impulsivity was very high, but
many GPs mislabelled conduct and oppositional defiant
symptoms as ADHD. This raises the possibility that when
children present with ADHD symptoms alone, GPs may
not recognise them as having ADHD.
GPs and ADHD treatment As would be expected in
gatekeeper settings, across studies, 71–94 % of GPs said
the overview of a specialist was required to treat ADHD;
ADHD symptom monitoring was not considered part of
their remit, although half or more were prepared to en-
gage in on-going prescribing and/or physical monitoring.
Almost all who were asked had little interest in becom-
ing more involved in ADHD care, citing lack of time
and knowledge.
GPs expressed mixed views about treating children
with medication generally. In Australia (2002), 43 % GPs
felt stimulants were suitable first-line treatments, but
17 % said they were always inappropriate; in Iran (2010),
75 % agreed ADHD can be managed with medication,
but 52 % of GPs believed only severe cases should receive
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it. In the UK (2005), most GPs stressed a combination ap-
proach to treatment (medication with psychosocial
techniques).
GP ADHD training and sources of information Most
studies did not report on ADHD-specific GP training.
Of those that did, just 6 % GPs in the UK and 10 % in
Iran had received this. GPs in all qualitative studies fre-
quently cited their lack of ADHD training and know-
ledge. Qualitative studies in Australia (2003) and the UK
(2000, 2005) indicated that GPs relied on media as a
source of ADHD information, as did about a quarter of
GPs in surveys (UK 2001; Iran, 2010). All studies con-
cluded that GP training in ADHD was needed.
Age, sex differences in knowledge, attitudes Finally,
just a few studies reported analyses of attitudes and
knowledge by GP age or gender and there was no pattern
of findings. Male GPs reported significantly higher com-
fort and skill in Canada, whereas female GPs did so in
Finland (Additional file 1: Table S1). Age-related differ-
ences in GP knowledge were examined in just one
Australia study but no significant differences were found.
Discussion
This review aimed to identify GP attitudes and know-
ledge regarding ADHD in children, and their role in
pathways to care, in jurisdictions where GPs are gate-
keepers and where guidelines recommend diagnosis and
treatment by specialist secondary services. This gate-
keeper model is found in many countries in Europe,
Canada, Australia, and elsewhere. The focus on such
settings was chosen, as nationally representative or
community-based studies in countries with gatekeeper
models of service (e.g., Ireland, UK, the Netherlands)
have found that only small proportions of children with
ADHD receive treatment [6–8]. As GPs control access
to ADHD diagnosis and services in such settings, their
awareness of ADHD and attitudes to it can affect a crit-
ical junction in the pathway to care.
The systematic review of papers found surprisingly few
studies of this topic, 11 studies (12 papers). Although di-
verse in focus, settings, time and measures, the studies
were found to have explored common topics of Recogni-
tion rate; ADHD controversy (medicalisation, stigma, la-
belling); Causes of ADHD; GPs and ADHD diagnosis;
GPs and ADHD treatment; GP ADHD training and
sources of information; and Age, sex differences in know-
ledge and attitudes.
Strikingly, across this diverse set of studies, GPs’ views
regarding causes, treatment and their role in ADHD
were found to have many similarities and to reflect recent
studies of other professionals, such as teachers, that high-
light persistent of misconceptions about ADHD and its
management [49]. As GPs are trained in the medical
model, one might predict their interpretations of chil-
dren’s ADHD-related difficulties would reflect the medical
consensus, which is primarily biomedical. Such views,
whilst present, were often overlaid with a (sometimes
more prevalent) focus on the impact of parenting. Given
the paucity and variability of the studies, the degree of
GPs’ scepticism regarding the construct of ADHD, and of
their negative views regarding paediatric ADHD medica-
tion, cannot be directly assessed, yet these beliefs or atti-
tudes appeared across many settings and throughout
the decade, reflecting other, more current reports of
voices against medicalisation of ADHD [10, 17, 36].
Such perspectives occur also in teachers and society in
general but are also reported (perhaps more alarmingly)
in child and adolescent mental health services (CAMHS)
where medication may be interpreted as a form of be-
haviour control and where competing ideologies regard-
ing ADHD have been found to lead to inter-professional
tensions [50]. Indeed, psychiatrists who support medica-
tion use and the existing ADHD evidence base also seek
to bring the focus more to social, family and educational
factors, asking about recent changes in the school sys-
tem or society that may cause parents and teachers to
feel less able to handle children with ADHD, and how
they might be better supported [25]. In the US, rises in
ADHD diagnoses in specific districts, line with the
introduction of mandatory testing in schools suggests
that the nature of the school environment, and/or per-
formance pressures on schools and districts, may under-
lie rising ADHD diagnosis rates [10]. In sum, the variety
of GPs’ views found in the present study, and their con-
cerns regarding medicalisation, are seen also in views of
other professionals, including those in mental health
[50, 51], and continue to contribute to the socially con-
tested nature of ADHD [1, 2, 10, 17, 19].
The presence of such views raises concern about GPs’
role in recognising ADHD in countries where they control
children’s access to services. This is supported by UK re-
search of the pathway to ADHD care, which indicates that
children with hyperactivity, but without additional behav-
iour problems, are likely to go unrecognised by the GP un-
less the parent requests referral [38]. It is further supported
by studies of parents, who have stated that GP scepticism
regarding ADHD, and focus on parenting advice, has pre-
vented discussion of children’s difficulties [47].
The finding that GPs are reluctant to be involved in
active ADHD care also raises questions about policy rec-
ommendations for shared care between mental health
services and primary care such as the UK NICE Recom-
mendations [26]. For example, recent reports from the
UK identified poor uptake in shared-care prescribing for
ADHD and GPs’ concerns for the robustness of the diag-
nosis [52]. In Ireland, nearly two-thirds of GPs foresaw
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difficulties with potential shared care between primary
care and psychiatric services [53] and only one-third to
half of GPs are reported to have had any formal training
in, or experience of working with, mental health issues
in general [54]; the proportion with ADHD training is
likely to be lower [55]. This raises concerns about the
level of oversight being delivered to the substantial pro-
portion of young people with ADHD who are trans-
ferred to GP care on leaving child and adolescent mental
health services where adult services typically do not take
on such cases [55]. Alternatives have been proposed,
such as a General Practitioner with Special Interest
(GPwSI) specialist model in the UK [56]. In the
Netherlands, a recently published controlled study
protocol for children with ADHD aims to reduce time
between referral and start of treatment, with accelerated
diagnosis and treatment plans, an online elearning train-
ing for primary care physicians, and enhanced co-
operation between primary and specialist care in child
mental health [57].
Strengths and limitations
This review benefited from a systematic, wide-ranging
search and is the first examination, to our knowledge, of
international GP/FP attitudes to ADHD in jurisdictions
where GPs are gatekeepers to ADHD services. It captures
views across four continents in the first decade of the 21st
century. Several studies were of large, randomly selected
samples with very good response rates (52–76 %) and a
combination of quantitative and qualitative studies enables
both depth and breadth to be accessed. At the same time
however it should be noted that only a limited number of
studies was identified and some were opportunistic sur-
veys. The use of different questionnaires in each study
means that caution should be employed when drawing
conclusions about attitudes across these studies, and dir-
ect comparisons of proportions of GPs holding certain
views across settings and times are not possible.
Furthermore, a skew towards the earlier part of the
decade means that many studies report attitudes that are
over a decade old. The limited range of studies (and
paucity of recent findings) is surprising and suggests an
urgent need for updated and more wide-ranging re-
search in this field: it is possible that GPs’ views may
have changed and may be influenced by the growing lit-
erature supporting biological contributions to ADHD
[17, 21]. One study of primary school teachers’ attitudes
to ADHD in Ireland [58] reported knowledge to be
greater relative to previous studies. However as this was
a small local study its findings remain to be supported
in Ireland and elsewhere. A recent review on ADHD
perceptions among healthcare professionals other than
GPs as well as teachers and the general public found
persisting misconceptions regarding ADHD etiology and
treatment in settings ranging from Sri Lanka to Canada
[46]. The authors conclude that these misconceptions
reinforce ADHD stigma, and called for continued educa-
tion about ADHD for all relevant professionals [46].
Indeed the possible role of stigma in GPs’ ADHD
recognition and referral process is another aspect of
ADHD that is worthy of further exploration. Stigma is
substantially under-investigated regarding ADHD, [57]
surprisingly so given Goffmann’s (1963) prediction
that stigma is more likely to be triggered for condi-
tions whose origins are uncertain or whose symptoms
are thought to be under the individual’s control [59] –
features of some GPs’ views of ADHD identified in
this review. Some GPs were reported to be reluctant
referrers, wishing to prevent children being exposed
to the stigma of a diagnosis, and expressing a fear of
‘labelling’ that has been noted by others [13]. Al-
though this stance regarding the adverse effect of a
diagnosis may be held with protective intent, it may
ultimately be to the detriment of a child with ADHD
should it preclude access to treatment.
Implications for training and services
GP education is one strategy to improve knowledge and
self-efficacy regarding mental health in general in chil-
dren and adults, and ADHD in particular, and can assist
with appropriate referral to services [60–62]. As no
definitive interventions or feasibility studies aiming to
enhance identification of ADHD in primary care were
identified in this review, this is an evident avenue that
requires further exploration.
However, it should be noted that training and in-
creased knowledge alone may not be enough to affect
GPs’ behaviour, [62, 63]. Sikorski and colleagues, in a
2012 systematic review of randomised control trials of
GP training in the care of depression, found very few
studies; the existing evidence led to the conclusion that
GP training alone does not improve care, but that train-
ing effects were more promising when combined with
implementation of guidelines, and that GP training
needs to be linked with more collaborative care models.
Notably, Canadian GPs, who had received autism edu-
cation, only raised a concern with parents regarding pos-
sible symptoms of a child’s autism if linked with
personal certainty about their clinical findings (sup-
ported by knowledge, screening and checklist tools) but
also a sense of urgency about taking this action [62].
This finding, if it is generalisable to ADHD, may be par-
ticularly pertinent, as GPs not only lack training but may
also be sceptical and hence may lack a sense of ‘urgency’
regarding referral and treatment. Furthermore, to ad-
dress the question of urgency, research suggests that it
would be necessary to train teachers, as well as to edu-
cate parents and other relevant family members. This is
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because studies of pathways to care [6, 13] and major re-
views [64] indicate that service access is affected by par-
ents’ and teachers’ knowledge about ADHD and their
interpretation of child behaviour, as well as referral re-
quests by parents. An exploration of such approaches
would seem warranted for ADHD, i.e., combining train-
ing, guideline implementation, checklists, and collabora-
tive care, with wider education for relevant professionals
and society.
In relation to services, in settings where national or pro-
fessional ADHD guidelines require secondary services to
diagnose and initiate treatment, they often also (as, e.g., the
UK NICE ADHD Guidelines) recommend the involvement
of GPs in shared care models [26]. This was reiterated
most recently in 2015 by Sayal [65] who noted the need for
involvement of primary care service partners, given the ex-
tent of ADHD prevalence and constraints on secondary
mental health service budgets. As this study indicates
mixed attitudes to the diagnosis itself among GP and, cru-
cially, very little interest at all in shared care, the import-
ance of identifying GPs’ current ADHD attitudes and
knowledge is highlighted once again.
Conclusions
This review identifies knowledge gaps among GPs re-
garding ADHD in many jurisdictions where they operate
as gatekeepers to ADHD care. Despite the limited num-
ber of studies found, their geographic breadth indicates
that mixed (and often unhelpful) attitudes regarding
the construct of ADHD are internationally wide-
spread, even among medically trained clinicians, in
these gatekeeper settings. Combined with prevalence
studies and investigations of pathways to care, the
findings suggests that education about ADHD is re-
quired not only for GPs but for all groups in the care
pathway, including parents, teachers and the public, to
enable parental concerns to be correctly identified and
managed, and to ensure appropriate access to special-
ist services. This training might address barriers to
parents’ perceptions of problems and to expression of
concerns regarding possible ADHD in primary care
consultations. It would also be valuable to work with
GPs, to ensure that they are alert to relevant concerns
and symptoms, and have adequate training and sup-
ports to respond accordingly.
Additional file
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gatekeeper GP attitudes and knowledge regarding ADHD. (PDF 1 mb)
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